Summary
This is a review of the 127 cases of drug-induced oesophagitis reported in the English language literature since 1970. The most common symptoms reported were retrosternal pain, odynophagia, and dysphagia. Most cases were self-limited and symptoms resolved in 7 to 10 days with symptomatic therapy. Occasionally, severe odynophagia or dysphagia necessitated hospitalisation. Emepronium bromide, tetracycline and its derivatives, potassium chloride, and quinidine account for 89% of the reported cases of medication-induced oesophageal injury. 14 other medications have been reported to injure the oesophagus. Serious sequelae, including death, have been linked to potassium-induced oesophageal injury. With other medications, however, serious complications were rare. The diagnostic study of choice is endoscopy; an air-contrast barium swallow may also detect the often subtle mucosal abnormalities produced by medication injury. However, the diagnosis does not require confirmation by radiographical or endoscopic means in all cases, and the history alone may be sufficient to make the diagnosis in uncomplicated cases. Medication-induced oesophageal injury is preventable if pills are taken with an adequate amount of fluid and if the practice of taking medications immediately before bedtime is avoided.
Similar content being viewed by others
References
Aarons B, Bruns BJ. Oesophageal ulceration associated with ingestion of doxycycline. New Zealand Medical Journal 91: 27, 1980
Abbarah TR, Fredell JE, Ellenz GB. Ulceration by oral ferrous sulfate. Journal of the American Medical Association 236: 2320, 1976
Agha FP, Wilson JAP, Nostrand TT. Medication-induced esophagitis. Gastrointestinal Radiology 11: 7–11, 1986
Allen AC, Boley SJ, Schultz L, et al. Potassium-induced lesions of the small bowel. Journal of the American Medical Association 193: 1001–1006, 1965
Amendola MA, Spera TD. Doxycycline induced esophagitis. Journal of the American Medical Association 253: 1009–1011, 1985
Applegate GR, Malmud LS, Rock E, et al. It’s a hard pill to swallow or don’t take it lying down. Gastroenterology 78: 1132, 1980
Barrison IG, Trewby PN, Kane SP. Oesophageal ulceration due to emepronium bromide. Endoscopy 12: 197–199, 1980
Bataille C, Soumagne D, Loly J, et al. Esophageal ulceration due to indomethacin. Digestion 24: 66–68, 1982
Bennett JR. Oesophageal ulceration due to emepronium bromide. Lancet 1: 810, 1977
Bohane TD, Perrault J, Fowler RS. Oesophagitis and oesophageal obstruction from quinidine tablets in association with left atrial enlargement. Australian Paediatric Journal 14: 191–192, 1978
Bokey L, Hugh TB. Oesophageal uiceration associated with doxycycline therapy. Medical Journal of Australia 1: 236–237, 1975
Boyce HW. Dysphagia after open heart surgery. Hospital Practice 20: 40–50, 1985
Burke EL. Acute oesophageal damage from one brand of tetracycline tablets. Gastroenterology 68: A–165/1022, 1975
Carlborg B. Biverkninger vid accidentall losning av lakemedel i esofagus och bronker. Lakartidningen 73: 4201–4204, 1976
Channer KS, Hollanders D. Tetracycline-induced oesophageal ulceration. British Medical Journal 282: 1359–1360, 1981
Chapman K. Emepronium bromide and the treatment of urge incontinence. Medical Journal of Australia 1: 103, 1978
Chessyre MH, Braimbridge MV. Dysphagia due to left atrial enlargement after mitral Starr valve replacement. British Heart Journal 33: 799–802, 1971
Collins FJ, Matthews HR, Baker SE, et al. Drug-induced oesophageal injury. British Medical Journal 1: 1673–1676, 1979
Cowan RE, Wright JT, Marsh F. Drug-induced oesophageal injury. British Medical Journal 2: 132–133, 1979
Creteur V, Laufer I, Kressel HY, et al. Drug-induced esophagitis detected by double-contrast radiography. Radiology 147: 365–368, 1983
Crowson TD, Head LH, Ferrante WA. Esophageal ulcers associated with tetracycline therapy. Journal of the American Medical Association 235: 2747–2748, 1976
Dent J, Dodds WJ, Friedman T, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. Journal of Clinical Investigation 65: 256–267, 1980
Doman DB, Ginsberg AL. The hazard of drug-induced esophagitis. Hospital Practice 16: 17–25, 1981
Elias PM, Fritsch PO. Erythema multiforme. In Fitzpatrick et al. (Eds) Dermatology in general medicine, 2nd ed., pp. 295–303, McGraw-Hill Book Co., New York, 1979
Enzenhaur RW, Bass JW, McDonnell JT. Esophageal ulceration associated with oral theophylline. New England Journal of Medicine 310: 261, 1984
Evans KT, Roberts GM. Where do all the tablets go? Lancet 2: 1237–1239, 1976
Evans KT, Roberts GM. The ability of patients to swallow capsules. Journal of Clinical and Hospital Pharmacology 6: 207–208, 1981
Froese EH. Oesophagitis with clindamycin. South African Medical Journal 56: 826, 1979
Geschwind A. Oesophagitis and oesophageal ulceration following ingestion of doxycycline tablets. Medical Journal of Australia 140: 223, 1984
Ginaldi S. Drug-induced esophagitis. American Family Practitioner 30: 169–170, 1984
Graham DY, Smith JL. Aspirin and the stomach. Annals of Internal Medicine 104: 390–398, 1986
Hachiya KA, Kobayashi RH, Antonson DL. Candida esophagitis following antibiotic usage. Pediatric Infectious Diseases 1: 168–169, 1982
Hale JE, Barnardo DE. Ulceration of mouth due to emepronium bromide. Lancet 1: 493, 1973
Hatheway GJ. Doxycycline-induced esophagitis. Drug Intelligence and Clinical Pharmacy 16: 879–880, 1982
Helm JF, Dodds WJ, Pelc LR, et al. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. New England Journal of Medicine 310: 284–288, 1984
Hey H, Jorgensen F, Sorensen K, et al. Oesophageal transit of six commonly used tablets and capsules. British Medical Journal 285: 717–719, 1982
Higson RH. Oesophagitis as a side effect of emepronium. British Medical Journal 2: 201, 1978
Hillman LC, Scobie BA. Acute oesophagitis due to emepronium bromide. New Zealand Medical Journal 94: 4–6, 1981
Hollis JB, Castell DO. A new look at ‘presbyesophagus’. Annals of Internal Medicine 80: 371–374, 1974
Hongo M, Traube M, McCallum RW. Comparison of effects of nifedipine, propantheline bromide, and the combination on esophageal motor function in normal volunteers. Digestive Diseases and Sciences 29: 300–304, 1984
Howie AD. Slow-release potassium chloride treatment. British Medical Journal 2: 176, 1975
Hughes R. Drug-induced oesophageal injury. British Medical Journal 2: 132, 1979
Israel RH. Esophagitis related to cromolyn. Journal of the American Medical Association 242: 2758–2759, 1979
Jeffery PC, Cullis SNR. Drug-induced esophagitis. South African Medical Journal 64: 1081, 1983
Jost PM. Drug-induced esophagitis. Journal of the American Medical Association 254: 508, 1985
Kavin H. Oesophageal ulceration due to emepronium bromide. Lancet 1: 424–425, 1977
Kenwright S, Norris ADC. Oesophageal ulceration due to emepronium bromide. Lancet 1: 548, 1977
Khera DC, Herschman BR, Sosa F. Tetracycline-induced esophageal ulcers. Postgraduate Medicine 68: 114–115, 1980
Kikendall JW, Friedman AC, Oyewole MA, et al. Pill-induced esophageal injury. Digestive Diseases and Sciences 28: 174–182, 1983
Lambert JR, Newman A. Ulceration and stricture of the esophagus due to oral potassium chloride therapy. American Journal of Gastroenterology 73: 508–511, 1980
Lowry N, Delaney P, O’Malley E. Oesophageal ulceration occurring secondary to slow release potassium tablets. Irish Journal of Medical Science 144: 366, 1975
Lubbe WF, Cadogen ES, Kannemeyer AHR. Oesophageal ulceration due to slow-release potassium in the presence of left atrial enlargement. New Zealand Medical Journal 90: 377–379, 1979
Mason DK, Chisholm DM. Salivary glands in health and disease, pp. 224–231, W.B. Saunders Co., Philadelphia, 1975
Mason SJ, O’Meara TF. Drug-induced esophagitis. Journal of Clinical Gastroenterology 3: 115–120, 1981
McCall AJ. Slow-K ulceration of oesophagus with aneurysmal left atrium. British Medical Journal 3: 230–231, 1975
McClean D. Drug-induced oesophageal ulcerations. British Medical Journal 282: 1975–1976, 1981
McCloy EC, Kane S. Drug-induced oesophageal ulceration. British Medical Journal 282: 1702, 1981
Mittal RK, Siskind BN, Hongo M, et al. Dysphagia aortica. Clinical, radiological, and manometric findings. Digestive Diseases and Sciences 31: 379–384, 1986
O’Meara TF. A new endoscopic finding of tetracycline-induced esophageal ulcers. Gastrointestinal Endoscopy 26: 106–107, 1980
Pemberton J. Oesophageal obstruction and ulceration caused by oral potassium therapy. British Heart Journal 32: 267–268, 1970
Peters JL. Benign oesophageal stricture following oral potassium chloride therapy. British Journal of Surgery 63: 698–699, 1976
Phaosawasdi K, Malmud LS, Tolin RD, et al. Cholinergic effects on esophageal transit and clearance. Gastroenterology 81: 915–920, 1981
Pilbrant A. Ulceration due to emepronium bromide tablets. Lancet 1: 749, 1977
Puhakka HJ. Drug-induced corrosive injury of the esophagus. Journal of Laryngology and Otology 92: 927–931, 1978
Riker J, Swanson M, Schweigen B. Esophageal ulceration by wax-matrix potassium chloride. Western Journal of Medicine 128: 542–543, 1978
Rose JD, Tobin GB. Drug-induced oesophagitis. British Medical Journal 280: 110, 1980
Rosenthal T, Adar R, Militiana J, et al. Esophageal ulceration and oral potassium chloride ingestion. Chest 65: 463–465, 1974
Schneider R. Doxcycline esophageal ulcers. Digestive Diseases and Sciences 22: 805–807, 1977
Scobie B. Reflux oesophagitis with emepronium therapy. New Zealand Medical Journal 89: 187, 1979
Seaman WB. The case of antibiotic dysphagia. Hospital Practice 14: 206–208, 1979
Shepperd HWH. Iatrogenic reflux oesophagitis. Journal of Laryngology and Otology 91: 171–172, 1977
Shirazi SS, Zike WL, Brubacher M, et al. Effect of aspirin, alcohol, and pepsin on mucosal permeability of esophageal mucosa. Gastroenterology 66: A–123/777, 1974
Stein MR, Thompson CK, Sawicki JE, et al. Esophageal stricture complicating Stevens-Johnson syndrome. American Journal of Gastroenterology 62: 435–439, 1974
Stillman AE, Martin RJ. Tetracycline-induced esophageal ulcerations. Archives of Dermatology 115: 1005, 1979
Sumithran E, Lim KH, Chiam HC. Atrio-oesophageal fistula complicating mitral valve disease. British Medical Journal 2: 1552–1553, 1979
Sutton DR, Gosnold JK. Oesophageal ulceration due to clindamycin. British Medical Journal 1: 1598, 1977
Symbas PN, Vlasis SE, Hatcher CR. Esophagitis secondary to ingestion of caustic material. Annals of Thoracic Surgery 36: 73–77, 1983
Teplick JG, Teplick SK, Ominsky SH. Esophagitis caused by oral medication. Radiology 134: 23–25, 1980
Tobias R, Cullis S, Kottler RE, et al. Emepronium bromide-induced esophagitis. South African Medical Journal 61: 368–370, 1982
Walsh J, Kneafsey DV. Phenobarbitone induced oesophagitis. Irish Medical Journal 73: 399, 1980
Walta DC, Giddens JD, Johnson LF, et al. Localized proximal esophagitis secondary to ascorbic acid ingestion and esophageal motor disorder. Gastroenterology 70: 766–769, 1976
Whitney B, Croxon R. Dysphagia caused by cardiac enlargement. Clinical Radiology 23: 147–152, 1972
Williams JG. Drug-induced oesophageal injury. British Medical Journal 2: 273, 1979
Woods JW, Manning IH, Peterson CN. Monilial infection complicating the therapeutic use of antibiotics. Journal of the American Medical Association 145: 207–211, 1951
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bott, S.J., McCallum, R.W. Medication-Induced Oesophageal Injury. Medical Toxicology 1, 449–457 (1986). https://doi.org/10.1007/BF03259855
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259855